Cramer: Allergan deal about 'facial domination'
June 17, 2015 at 10:28 AM EDT
Allergan's acquisition of Kythera Biopharmaceuticals expands the company's footprint of the facial treatment space, CNBC's Jim Cramer said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
